Sanofi Ventures
Venture capital · Cambridge, Massachusetts, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
16Deep-tech portfolio10 active
6Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Fulcrum Therapeutics
45Co-investorsShare a portfolio company
Portfolio · 16 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Character Bio | Biotech | Active | — | — |
| Diagonal Therapeutics | Biotech | Active | — | — |
| Draig Therapeutics | Biotech | Active | — | — |
| Expedition Therapeutics | Biotech | Active | — | — |
| F2G | Biotech | Active | — | — |
| Granite Bio | Biotech | Active | — | — |
| Kymera Therapeutics | Biotech | Active | — | — |
| OMass Therapeutics | Biotech | Active | — | — |
| Owkin | Biotech | Active | — | — |
| SpliceBio | Biotech | Active | — | — |
| Fulcrum Therapeutics | Biotech | Public | Jun 11, 2020 | $170.5M |
| Translate Bio | Biotech | Acquired | May 10, 2019 | $98.5M |
| Ovid Therapeutics | Biotech | Public | Jan 20, 2017 | $105.9M |
| Acelyrin | Biotech | Acquired | — | — |
| Attovia Therapeutics | Biotech | Public | — | — |
| Korsana Biosciences | Biotech | Public | — | — |
Peer ranks
Portfolio size#24
Portfolio exits#31
Raises, 12 months#88
Co-investors#37
Co-investors
- Biotechnology Value FundVenture capital3 shared
- SR OneVenture capital3 shared
- Access BiotechnologyVenture capital2 shared
- Atlas VentureVenture capital2 shared
- Canaan PartnersVenture capital2 shared
- EcoR1 CapitalVenture capital2 shared
- ForbionVenture capital2 shared
- Logos CapitalVenture capital2 shared
- SV Health InvestorsVenture capital2 shared
- Third Rock VenturesVenture capital2 shared
Sectors
- Biotech16
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.